Simpson Thacher & Bartlett is representing Karuna Therapeutics, Inc. in the transaction.Bristol-Myers Squibb Company (“BMS”, NYSE: BMY) announced its acquisition of Karuna Therapeutics, Inc. (“Karuna”) for $330 in…
Simpson Thacher & Bartlett is representing Karuna Therapeutics, Inc. in the transaction.Bristol-Myers Squibb Company (“BMS”, NYSE: BMY) announced its acquisition of Karuna Therapeutics, Inc. (“Karuna”) for $330 in…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.